These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38370104)

  • 1. Seroprevalence of poliovirus antibodies in Nigeria: refining strategies to sustain the eradication effort.
    Bolu O; Adamu U; Franka R; Umeokonkwo CD; An Q; Greby S; McDonald S; Mainou B; Mba N; Agala N; Archer WR; Braka F; Etapelong SG; Gashu TS; Siddique AR; Asekun A; Okoye M; Iriemenam N; Wiesen E; Swaminathan M; Ihekweazu C; Shuaib F
    Pan Afr Med J; 2023; 45(Suppl 2):2. PubMed ID: 38370104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010.
    Cardemil CV; Jonas A; Gerber S; Weldon WC; Oberste MS; Beukes A; Sawadogo S; Patel SV; Zeko S; Muroua C; Gaeb E; Wannemuehler K; Goodson JL
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S136-42. PubMed ID: 25316828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
    Hendry AJ; Beard FH; Dey A; Quinn H; Hueston L; Dwyer DE; McIntyre PB
    Vaccine; 2020 Mar; 38(11):2572-2577. PubMed ID: 32037225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
    Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
    BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
    Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
    Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
    Opare JK; Akweongo P; Afari EA; Odoom JK
    Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
    Khetsuriani N; Pallansch MA; Jabirov S; Saparova N; Oberste MS; Wannemuehler K; Ursu P; Wassilak S; Martin R
    Vaccine; 2013 Oct; 31(42):4911-6. PubMed ID: 23891502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016.
    Ahmad M; Verma H; Kunwar A; Soni S; Sinha U; Gawande M; Sethi R; Nalavade U; Sharma D; Bhatnagar P; Bahl S; Deshpande J
    Int J Infect Dis; 2021 Jan; 102():337-343. PubMed ID: 33130206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
    Bianchi FP; Larocca AMV; Bozzi A; Spinelli G; Germinario CA; Tafuri S; Stefanizzi P
    Vaccine; 2021 May; 39(22):2989-2994. PubMed ID: 33933314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.
    Saleem AF; Mach O; Quadri F; Khan A; Bhatti Z; Rehman NU; Zaidi S; Weldon WC; Oberste SM; Salama M; Sutter RW; Zaidi AK
    Vaccine; 2015 Jun; 33(24):2757-63. PubMed ID: 25917673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
    Giwa FJ; Olayinka AT; Ogunshola FT
    Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of poliovirus antibodies in Kano, Northern Nigeria.
    Iliyasu Z; Nwaze E; Verma H; Mustapha AO; Weldegebriel G; Gasasira A; Wannemuehler KA; Pallansch MA; Gajida AU; Pate M; Sutter RW
    Vaccine; 2014 Mar; 32(12):1414-20. PubMed ID: 24041545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria.
    Verma H; Iliyasu Z; Craig KT; Molodecky NA; Urua U; Jibir BW; Gwarzo GD; Gajida AU; McDonald S; Weldon WC; Oberste MS; Braka F; Mkanda P; Sutter RW
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S103-S109. PubMed ID: 30376090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study.
    Tan Q; Zhu Q; Zheng H; Zhang B; Wu C; Guo X; Li H; Liu L; Liu Y; Rutherford S; Zheng H
    Hum Vaccin Immunother; 2018; 14(11):2644-2648. PubMed ID: 30059644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria.
    Iliyasu Z; Verma H; Craig KT; Nwaze E; Ahmad-Shehu A; Jibir BW; Gwarzo GD; Gajida AU; Weldon WC; Steven Oberste M; Takane M; Mkanda P; Muhammad AJG; Sutter RW
    Vaccine; 2016 Sep; 34(42):5125-5131. PubMed ID: 27591950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants.
    Kaliappan SP; Venugopal S; Giri S; Praharaj I; Karthikeyan AS; Babji S; John J; Muliyil J; Grassly N; Kang G
    Vaccine; 2016 Sep; 34(41):4979-4984. PubMed ID: 27566901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria.
    Gofama MM; Verma H; Abdullahi H; Molodecky NA; Craig KT; Urua UA; Garba MA; Alhaji MA; Weldon WC; Oberste MS; Braka F; Muhammad AJG; Sutter RW
    PLoS One; 2017; 12(9):e0185284. PubMed ID: 28949979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.
    Díaz-Quiñónez JA; Díaz-Ortega JL; Cruz-Hervert P; Ferreira-Guerrero E; Delgado-Sánchez G; Ferreyra-Reyes L; López-Martínez I; Torres-Longoria B; Aparicio-Antonio R; Montero-Campos R; Mongua-Rodríguez N; Garcia-Garcia L
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S110-S114. PubMed ID: 30376082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study.
    Xu J; Kuang S; Rong R; Zhang Y; Tang W; Wang Q
    Medicine (Baltimore); 2020 Jul; 99(31):e21298. PubMed ID: 32756110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.